Proteases of Pseudomonas aeruginosa in patients with cystic fibrosis

The Journal of Infectious Diseases
G DöringA Hofmann

Abstract

Radioimmunoassays were used to determine titers of antibody to alkaline protease (AP) and elastase (Ela) produced by Pseudomonas aeruginosa in sera and bronchial secretions, in vitro production of AP and Ela by P. aeruginosa isolates, and occurrence of these enzymes in bronchial secretions from patients with cystic fibrosis. Titers of serum antibodies to AP ranging from 1:10 to 1:545 and to Ela ranging from 1:10 to 1:725 were found in 83%-88% of patients with cystic fibrosis and chronic lung infections due to P. aeruginosa. Antibody titers in liquified bronchial secretions were approximately 10% of the serum titers. Thirty-one (93%) of 34 isolates produced both proteases in vitro in comparable amounts (concentration of protease in culture supernatant: AP, 0.01-480 micrograms/ml; Ela, 0.02-490 micrograms/ml). AP and Ela were detected in vivo when antibodies to the enzymes were absent. The results suggest that specific immune responses in patients with cystic fibrosis neutralize proteases of P. aeruginosa.

Citations

Apr 1, 1985·European Journal of Clinical Microbiology·M GranströmM L Vasil
Feb 13, 2001·International Journal of Antimicrobial Agents·F Ratjen
Jan 1, 1991·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·A Kharazmi, H Nielsen
Jul 29, 2005·Antimicrobial Agents and Chemotherapy·Ewa Ołdak, Elzbieta A Trafny
May 1, 1987·Archives of Disease in Childhood·R H George
Sep 1, 1993·The American Review of Respiratory Disease·A Buret, A W Cripps
Feb 12, 2005·American Journal of Respiratory Cell and Molecular Biology·Sophie DulonMichel Chignard
Mar 21, 2006·American Journal of Respiratory Cell and Molecular Biology·Michel Chignard, Dominique Pidard
Jun 1, 1995·The Journal of Clinical Investigation·R A Miller, B E Britigan
May 1, 1992·European Journal of Clinical Chemistry and Clinical Biochemistry : Journal of the Forum of European Clinical Chemistry Societies·J SaulnierM Guinand
Dec 1, 1994·European Journal of Clinical Chemistry and Clinical Biochemistry : Journal of the Forum of European Clinical Chemistry Societies·M C Jaffar-BandjeeC Galabert
Jul 1, 1987·Infection·R Ramphal, S Vishwanath
Jan 1, 1992·Experimental Lung Research·J C WilliamsJ Donahue
Nov 1, 1988·Zentralblatt Für Bakteriologie, Mikrobiologie, Und Hygiene. Series A, Medical Microbiology, Infectious Diseases, Virology, Parasitology·P KubeschB Tümmler
Feb 19, 2009·European Journal of Immunology·Jenna B AllardLaurie A Whittaker
May 1, 1986·The Journal of Pediatrics·M L Vasil
Jun 19, 1998·Biochimica Et Biophysica Acta·A DohrmanC Basbaum
Jun 18, 2005·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·G A Tramper-StrandersT F W Wolfs
Jan 1, 1989·Pediatric Pulmonology·G SteinkampH von der Hardt
Jan 1, 1990·Pediatric Pulmonology·M S Zach
Sep 1, 1987·Pediatric Pulmonology·M J ThomassenC F Doershuk
May 5, 2004·The Journal of Biological Chemistry·John F Alcorn, Jo Rae Wright
Dec 2, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Alexander J LaarmanSuzan H M Rooijakkers

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.